The decision by biotechnology firm Turing Pharmaceuticals to raise the cost of Pyrimethamine (or Daraprim), a drug used to treat toxoplasmosis, from $13.50 to more than $750 per pill, has aroused shock and outrage. Toxoplasmosis is a parasitic disease to which people with weakened immune systems from of diseases such as AIDS, as well as certain cancer patients, as well as unborn babies, are susceptible.
The more than 4,000 percent overnight price jump would have deprived large numbers of people of a desperately needed medication.
